Drugs / BXP154B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06205615 | Jan → Mar 2024 | bleeding disorder, vascular-type | Bio 54, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BXP154B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06205615 ↗ |
| Known as | Tranexamic Acid Sterile Topical Solution | “BXP154B (Tranexamic Acid Sterile Topical Solution)” NCT06205615 ↗ |
| Route | Topical | “BXP154B will be self-administered topically following wound induction” NCT06205615 ↗ |